# FDA Inspection 1017417 - Bayer Healthcare Pharmaceuticals Inc. - June 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/bayer-healthcare-pharmaceuticals-inc/059c63a3-3fcd-4680-8b06-5dcde17e54b7
Source feed: FDA_Inspections

> FDA Inspection 1017417 for Bayer Healthcare Pharmaceuticals Inc. on June 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017417
- Company Name: Bayer Healthcare Pharmaceuticals Inc.
- Inspection Date: 2017-06-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1286004 - 2025-10-20](https://www.keypedia.com/records/fda_inspections/bayer-healthcare-pharmaceuticals-inc/df68611f-7087-43a2-acd9-e7888f39c386)
- [FDA Inspection 1286004 - 2025-10-20](https://www.keypedia.com/records/fda_inspections/bayer-healthcare-pharmaceuticals-inc/3ee51030-3bcb-4a86-9851-8fa708195f4a)
- [FDA Inspection 1277153 - 2025-08-15](https://www.keypedia.com/records/fda_inspections/bayer-healthcare-pharmaceuticals-inc/7fdf8caf-615c-4401-9f50-05def118c4e8)
- [FDA Inspection 1277153 - 2025-08-15](https://www.keypedia.com/records/fda_inspections/bayer-healthcare-pharmaceuticals-inc/f2b7ea39-791c-4d2a-a6cf-3159457ae2eb)
- [FDA Inspection 1251837 - 2024-12-17](https://www.keypedia.com/records/fda_inspections/bayer-healthcare-pharmaceuticals-inc/a70ed447-dee5-4251-b438-c57e0b0baa20)

Company: https://www.keypedia.com/companies/bayer-healthcare-pharmaceuticals-inc/ee43940d-d6bd-4b20-a758-d7ca5fbc322f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c